A multi-center, open-label study evaluating the efficacy and safety of Rituxan [rituximab] in combination with cyclophosphamide/doxorubicin, vincristine and prednisone chemotherapy following by Rituxan maintenance as initial therapy for patients with aggressive non-Hodgkin's lymphoma
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 22 Dec 2005
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Dec 2005 New trial record.